PtdIns(3,4,5)P3-Dependent Activation of the mTORC2 Kinase Complex
What this study shows
PIP3 relieves SIN1 PH-domain autoinhibition to activate the mTORC2 kinase complex.
At a glance
| Evidence type | M Molecular — cells, biochemistry, structure Marked M because it is molecular or in-vitro work (model: Mammalian cells) rather than a whole-organism health-outcome study. That is often exactly where causal biology gets established -- the code says which system the finding was shown in, and nothing about how good the work is. |
| Study type | 5 - Mechanistic / In Vitro |
| Model system | Mammalian cells |
| Journal | Cancer discovery |
| Year | 2015 |
| Peer reviewed | Yes |
| Record last updated | 2026-10-01 |
| Source | DOI 10.1158/2159-8290.CD-15-0460 · PMID 26293922 · Free full text (PMC4631654) |
Extracted findings
These fields were extracted from the paper with AI assistance and have not been checked against the source. Read them as a pointer into the paper, not as curated claims; where they disagree with the curated summary above, the curated summary stands.
| Intervention | Biochemical/genetic (SIN1 PH domain) |
| Target | mTORC2 / SIN1 / PtdIns(3,4,5)P3 |
| Model | Mammalian cells |
| Effect | PIP3 binds the SIN1 PH domain to relieve suppression of mTOR → activates mTORC2 |
In the Atlas
Links in the pathway map
- Supports mTORC2 activates Akt/PKB
- Supports PI3K activates Akt/PKB
- Supports PI3K activates mTORC2
Was this page useful?
Thank you. Your answer was counted anonymously.